Seattle Genetics (SGEN) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Investment income, net: 660K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Investment income, net: 660K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Seattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.13), $0.11 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $75.8 million versus the consensus estimate of $66.9 million.
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Ross Stores raises 2026 outlook after strong second-quarter results
- Largo restructures $82.2M in debt, extending maturity to 2030
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
